Market Overview

Samsung Electronics reported a preliminary third-quarter operating profit of 107.40 trillion won, or about $80.2 billion, marking a nearly nine-fold increase from 12.17 trillion won a year earlier. The figure beats the LSEG SmartEstimate of 106.1 trillion won and represents the company's fourth consecutive quarter of record operating earnings. Quarterly revenue is expected to reach 195 trillion won, up roughly 127 percent from the same period last year. The surge reflects booming demand for artificial intelligence infrastructure that has outstripped global memory chip supply. Higher prices for conventional DRAM and NAND chips, alongside growing shipments of high-bandwidth memory for AI applications, drove the results. At the same time, the memory boom has raised component costs for Samsung's own smartphone and consumer electronics divisions, squeezing margins in those units. Meanwhile, its contract chipmaking business remains loss-making due to fixed costs and low utilization rates. The company plans to release its full third-quarter earnings, including a divisional breakdown, on October 29.

Bbc

Space Exploration Technologies is seeking $40 billion in new debt financing to purchase artificial intelligence chips from Nvidia. Apollo Global Management is expected to lead the transaction, which comprises $10 billion in bank loans and $30 billion in investment-grade debt. The transaction is not expected to close until 2027. SpaceX reported revenue of $7.81 billion against capital expenditures of $18.37 billion during the second quarter, leaving free cash flow negative at $25 billion through the first six months of the year as the company simultaneously invested in AI data centers, Starlink, and Starship. CEO Elon Musk stated that SpaceX will build its data centers exclusively using Nvidia hardware, with the company's cumulative compute capacity approaching 10 gigawatts by the end of 2027. Nvidia collects revenue when the hardware ships, while SpaceX carries the debt obligations on its balance sheet for years. The massive borrowing mirrors broader trends across the technology sector, where artificial intelligence hyperscalers increasingly tap debt markets to fund infrastructure build-outs. Financing remains in the discussion stage as terms and the final lender group take shape.

Cnbc

Broadcom is working to arrange more than $50 billion in private financing to build custom artificial intelligence chips for OpenAI. The package could pay for several gigawatts of OpenAI chip capacity and could close before the end of 2026. Broadcom has approached lenders including Apollo Global Management and Blackstone for the early-stage talks. The financing follows a partnership the two companies announced a year earlier to develop 10 gigawatts of OpenAI custom chips on Broadcom networking technology, with systems entering service from the second half of 2026 through the end of 2029. Rising artificial intelligence build-out costs have pushed major technology and hardware providers beyond internal cash flow and the public bond market. Broadcom shares slipped about 0.2% to roughly $375.70 after the market close on Tuesday, following a small gain in the regular session.

Stocktwits

Microsoft and Nvidia unveiled the Surface Laptop Ultra at an event in San Francisco on Wednesday, introducing a high-end machine powered by Nvidia's Blackwell-based RTX Spark chip designed to run AI models and agents locally. The laptop starts at $2,599 for the base model, with higher configurations reaching up to $5,900, alongside a dedicated workstation version called the Surface RTX Spark Dev Box priced starting at $6,000. The devices feature up to 128 gigabytes of unified memory and are built to handle intensive workloads including image and video generation, which Microsoft demonstrated as being several times faster than competing machines utilizing Apple's M5 Pro chip. The hardware release coincides with a revamped version of Windows 11 featuring Execution Containers to sandbox AI agents securely on the device, reducing reliance on cloud infrastructure like Microsoft's Azure data centers. The high price points, driven by surging memory costs across the industry, position the new hardware primarily toward developers and enterprise early adopters. Microsoft is offering up to $1,000 off to customers who trade in a MacBook Pro toward the purchase of the new Surface devices.

Techcrunch

Google contracted for 3,590 megawatts of power from Constellation Energy in a 20-year power purchase agreement, with new nuclear energy accounting for about a quarter of that supply. The deal enables more than $4.3 billion of new investment by Constellation and involves adding capacity at 11 nuclear units located in Illinois, Pennsylvania, and New Jersey. Electricity from the first of the upgraded plants is expected to be delivered in 2028. Google also entered into a long-termed supply agreement for an additional 2,700 megawatts of power from Constellation in PJM, serving as revenue certainty for the operating plants. The agreement responds to a proposal by PJM management requiring data center customers to bring their own power or face shutoffs during peak demand.

Channelnewsasia

Google DeepMind, Alphabet drug discovery unit Isomorphic Labs, and Meta Platforms have committed a combined $300 million to the Chan Zuckerberg Biohub to build AI models for biological research. Wednesday's announcement brings total funding for the Virtual Biology Initiative to $1.8 billion across public and private backers. The Department of Energy is directing more than $500 million over five years toward lab measurement and modeling through the Genesis Mission, while the National Institutes of Health is contributing datasets built from over $500 million in prior federal funding. Biohub previously committed $500 million to the project in April. The initiative will measure cellular responses across an unprecedented scale of conditions to create predictive digital models of cell behavior. Commercial contributors receive a one-year embargo on the resulting data before it enters the public domain, while government-funded work carries no such restrictions. Biohub aims to produce the first dataset in about a year and functional predictive models within five years. Alphabet and Meta's combined $300 million investment is modest relative to their broader capital allocation, as Alphabet spent $91.45 billion on capex in 2025 and Meta spent $69.69 billion. Participants in the effort also include the Allen Institute, Broad Institute, Gladstone Institutes, the Human Cell Atlas, the Human Protein Atlas, the Wellcome Sanger Institute, and NVIDIA, which is providing computing infrastructure.

Theverge

Poland's Office of Competition and Consumer Protection accused Alphabet's Google of abusing its dominant market position during negotiations over content payments with domestic media publishers. The regulator, known as UOKiK, stated that Google failed to provide publishers with necessary data to assess compensation offers for articles displayed in search results, Google News, and Discover services. Tomasz Chrostny, president of UOKiK, said the information imbalance prevented fair negotiations and allowed Google to impose terms. The dispute follows a 2024 Polish copyright law amendment implementing an EU directive that requires online services to remunerate press publishers. Google Poland responded that it is reviewing the decision and maintains licensing deals with over 70 publications in the country. The maximum penalty for the alleged violation could reach 10 percent of the company's annual turnover. UOKiK noted that the investigation operates independently from a separate European Commission probe opened in December 2025 regarding compensation for AI services.

Engadget

Clayton Dubilier & Rice and McKesson agreed to take Option Care Health private in a transaction valuing the infusion therapy provider at $5.8 billion. Under the terms of the agreement, Option Care Health stockholders will receive $32.05 per share in cash, representing a 37 percent premium over the company's closing price on October 5, 2026. The purchase shifts the country's largest independent alternate site infusion provider out of the public markets and into a private ownership structure split between two sponsors. Clayton Dubilier & Rice will hold a 51 percent majority stake in the company, while McKesson is investing approximately $1.4 billion for a 49 percent minority interest. The transaction also establishes a framework allowing McKesson to acquire Clayton Dubilier & Rice's interest at a later date. Option Care Health generated more than $5.6 billion in net revenue and $207.6 million in net income in 2025, followed by modest gains through the first half of 2026. The company operates across all 50 states, serves over 308,000 patients annually, and employs 8,000 workers, including 5,000 clinicians. McKesson's strategic rationale centers on expanding its footprint in specialty care and alternate site delivery as demand for complex therapies rises outside traditional hospital settings. The deal requires customary regulatory clearances and shareholder approval before it can proceed. Both companies expect the acquisition to close in the first half of 2027, at which point Option Care Health's common stock will delist from the Nasdaq Stock Exchange.

Fiercehealthcare

POSCO Future M signed a expanded 21.25 trillion won long-term battery materials supply contract with Samsung SDI through 2032. The new agreement adds lithium iron phosphate cathode materials to an existing nickel-cobalt-aluminum supply deal originally signed in 2023. The LFP addition accounts for 6.05 trillion won of the total value, while the NCA portion represents 15.2 trillion won. The combined supply volume rose about 45 percent, with the LFP volume doubling to at least 380,000 metric tons for delivery from 2027 through 2032. Total contract value fell from roughly 40 trillion won when the 2023 deal was first announced due to lower lithium prices reducing per-unit selling figures. The companies plan to extend their partnership to lithium manganese oxide cathode materials and artificial graphite anode materials. POSCO Future M also secured a 1.1 trillion won LFP cathode supply contract with SK On spanning 2027 through 2029 with a two-year extension option. The agreements establish a non-prohibited foreign entity supply chain for South Korean battery manufacturers complying with United States regulations.

Biz Heraldcorp

GE HealthCare agreed to acquire SOFIE Biosciences from Trilantic North America for $945 million in cash. The purchase price will be funded in cash, adding a network of 15 U.S. contract manufacturing organization sites operating 21 cyclotrons to GE HealthCare's Pharmaceutical Diagnostics segment. The transaction includes U.S. rights to FAPI-74, a Phase III pipeline PET radiotracer with pan-cancer imaging potential. SOFIE Biosciences currently manufactures Flyrcado, a flurpiridaz F18 injection product for GE HealthCare. Following the completion of the deal, SOFIE Biosciences will continue to operate as an independent manufacturing partner to its existing customers while supplying products from other providers. GE HealthCare expects the acquisition to be accretive to revenue growth, adjusted earnings before interest and taxes margin, and adjusted earnings per share in the first full year of ownership. BofA Securities, Consello Financial LLC, and Solomon Partners Securities LLC served as financial advisors for GE HealthCare. The transaction is expected to close in the first half of 2027, subject to customary closing conditions and regulatory approvals.

Biospace